Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.920
-0.110 (-3.63%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
61
Market Cap
211.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Protalix BioTherapeutics | 80.62M |
| Coherus Oncology | 50.94M |
| Precision BioSciences | 45.06M |
| Voyager Therapeutics | 34.46M |
| Innate Pharma | 10.57M |
| Oramed Pharmaceuticals | 2.00M |
ABOS News
- 17 days ago - Acumen Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 17 days ago - Acumen Pharmaceuticals Earnings release: Q2 2026 - Filings
- 17 days ago - Acumen Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 17 days ago - Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 18 days ago - Acumen Pharmaceuticals Slides: Corporate presentation - Filings
- 24 days ago - Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026 - GlobeNewsWire
- 6 weeks ago - Acumen presents new findings at AAIC conference - TheFly
- 6 weeks ago - Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer's Disease Insights at the Alzheimer's Association International Conference (AAIC®) 2026 - GlobeNewsWire